Why the CSR share price is falling today

What's next for the CSR share price following the company's update to investors on how the construction industry is fairing during COVID-19.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSR Limited (ASX: CSR) share price has fallen 1.57% on the back of its annual general meeting (AGM) held today. CSR is a leading building products company in Australia and New Zealand which has been in operation for 165 years. 

The AGM follows the release of the company's full year results for year ended 31 March 2020 (YEM20) in which it delivered a statutory net profit of $125 million.

The CSR share price has fallen 7.4% over the past 12 months. This is in contrast to the S&P/ASX200 Index (ASX: XJO) which has declined 10.3%.

Let's discuss the trading results, financial position and outlook released in the AGM announcement today.

assortment of construction materials, building shares, boral share price

Image source: Getty Images

Trading results

Managing director Julie Coates gave an update on the trading results in her address at the AGM:

"For the first 11 weeks of the current financial year (on a like for like basis), building products revenue in Australia is down 3%. Including the impact of New Zealand COVID-19 restrictions, the decline is 5%."

The trading results were in line with CSR's expectations of a slowdown in activity. As a result of the continuing uncertainty surrounding coronavirus, no guidance was provided by the company for YEM21.

Financial position

CSR's financial position remains strong with a net cash position of $95 million at 31 March 2020. An additional $200 million facility is available should the need arise.

The company has decided to pause dividends and its share buyback, again due to uncertain economic outlook. Before the pause, CSR had returned $69 million in dividends in YEM20 and more than $69 million in an on-market share buyback which commenced in March 2019.

Outlook

Julie Coates gave some guidance regarding the outlook for the construction industry.

"Current lead indicators such as new homes sales in Australia during April and May are down 19% compared to the same period last year. This provides some indication of lower activity expected later in the year due to the lag in demand for our products, noting there will also be benefit from the announced government stimulus measures, but the timing and extent remains uncertain."

The government stimulus Julie is referring to is the federal government's $25,000 HomeBuilder grant. This provides eligible owner-occupiers with cash to substantially renovate an existing home.  

Is the CSR share price a buy?

In my view, an investment in CSR Limited looks to be risky in light of the downturn in new home sales. Furthermore, it's too early to tell if the government stimulus will have its desired impact on the construction industry. From my perspective, this assistance also serves to reinforce the severity of the downturn facing the sector. 

Having said that, weakness in this cyclical industry could be a great entry point for the contrarian investor as the industry recovers. 

Motley Fool contributor Matthew Donald has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Healthcare Shares

Why are Telix shares racing 8% higher today?

Telix shares are now 11% higher for the year-to-date.

Read more »